131 related articles for article (PubMed ID: 8554976)
1. Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
Cameron ER; Campbell M; Blyth K; Argyle SA; Keanie L; Neil JC; Onions DE
Br J Cancer; 1996 Jan; 73(1):13-7. PubMed ID: 8554976
[TBL] [Abstract][Full Text] [Related]
2. CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.
Kubo S; Hasegawa A; Hashimoto K; Shimizu C; Kubo M; Tada T; Nakayama T
Immunology; 1997 Dec; 92(4):437-46. PubMed ID: 9497484
[TBL] [Abstract][Full Text] [Related]
3. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC
Int J Cancer; 1993 Apr; 53(6):1023-30. PubMed ID: 8473043
[TBL] [Abstract][Full Text] [Related]
4. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice.
Nawijn MC; Ferreira R; Dingjan GM; Kahre O; Drabek D; Karis A; Grosveld F; Hendriks RW
J Immunol; 2001 Jul; 167(2):715-23. PubMed ID: 11441075
[TBL] [Abstract][Full Text] [Related]
5. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
[TBL] [Abstract][Full Text] [Related]
6. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
[TBL] [Abstract][Full Text] [Related]
7. The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene.
Zaidi NH; Allay E; Ayi TC; Li BF; Dumenco LL; Sy MS; Gerson SL
Carcinogenesis; 1995 May; 16(5):1047-53. PubMed ID: 7767963
[TBL] [Abstract][Full Text] [Related]
8. Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?
Webster G; Onions DE; Neil JC; Cameron ER
Br J Cancer; 1997; 76(6):739-46. PubMed ID: 9310239
[TBL] [Abstract][Full Text] [Related]
9. Response of V beta 8.1+ T cell clones to self Mls-1a: implications for the origin of autoreactive T cells.
Yui K; Katsumata M; Komori S; Gill-Morse L; Greene MI
Int Immunol; 1992 Feb; 4(2):125-33. PubMed ID: 1352459
[TBL] [Abstract][Full Text] [Related]
10. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of presence and functional activity of potentially self-reactive T cells in aged mice.
Crisi GM; Tsiagbe VK; Russo C; Basch RS; Thorbecke GJ
Int Immunol; 1996 Mar; 8(3):387-95. PubMed ID: 8671625
[TBL] [Abstract][Full Text] [Related]
12. TCR v(beta) repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas.
Gomez G; Clarkin KZ; Kraig E; Infante AJ; Richie ER
Int Immunol; 2000 Mar; 12(3):263-70. PubMed ID: 10700461
[TBL] [Abstract][Full Text] [Related]
13. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
Smith DP; Bath ML; Harris AW; Cory S
Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
[TBL] [Abstract][Full Text] [Related]
14. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
Schulz R; Mellor AL
J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
[TBL] [Abstract][Full Text] [Related]
15. The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells.
Fink PJ; Fang CA; Turk GL
J Immunol; 1994 May; 152(9):4270-81. PubMed ID: 7908916
[TBL] [Abstract][Full Text] [Related]
16. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
Giese T; Davidson WF
Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection.
Berg LJ; Fazekas de St Groth B; Pullen AM; Davis MM
Nature; 1989 Aug; 340(6234):559-62. PubMed ID: 2528070
[TBL] [Abstract][Full Text] [Related]
18. A CD2-green fluorescence protein-transgenic mouse reveals very late antigen-4-dependent CD8+ lymphocyte rolling in inflamed venules.
Singbartl K; Thatte J; Smith ML; Wethmar K; Day K; Ley K
J Immunol; 2001 Jun; 166(12):7520-6. PubMed ID: 11390506
[TBL] [Abstract][Full Text] [Related]
19. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
20. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
